Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 82
Filtrar
1.
Am J Physiol Endocrinol Metab ; 316(1): E16-E33, 2019 01 01.
Artigo em Inglês | MEDLINE | ID: mdl-30153063

RESUMO

Polycystic ovary syndrome (PCOS) is highly associated with cardiometabolic risk and the metabolic syndrome (MetS), predisposing women to increased risk of developing type 2 diabetes and cardiovascular disease. Metformin is commonly used to treat insulin resistance-glucose intolerance, and flutamide, an androgen receptor (AR) antagonist, is used to target hyperandrogenemia and dyslipidemia. Currently, the physiological mechanism of action of these treatments on androgen, lipidogenic, and insulin signaling pathways remains unclear in PCOS. The aim of this study was to investigate the effects and mechanisms of action of metformin and flutamide on plasma lipid-apolipoprotein (Apo)B-lipoprotein and insulin-glucose metabolism, and endocrine-reproductive indices in a PCOS-prone MetS rodent model. PCOS-prone rodents were treated with metformin (300 mg/kg body wt), flutamide (30 mg/kg body wt), or metformin + flutamide combination treatment for 6 wk. Metformin was shown to improve fasting insulin and HOMA-IR, whereas flutamide and combination treatment were shown to reduce plasma triglycerides, ApoB48, and ApoB100, and this was associated with decreased intestinal secretion of ApoB48/triglyceride. Flutamide and metformin were shown to reduce plasma androgen indices and to improve ovarian primary and preovulatory follicle frequency. Metformin treatment increased hepatic estrogen receptor (ER)α, and metformin-flutamide decreased intestinal AR and increased ERα mRNA expression. Metformin-flutamide treatment upregulated hepatic and intestinal insulin signaling, including insulin receptor, MAPK1, and AKT2. In conclusion, cardiometabolic risk factors, in particular ApoB-hypertriglyceridemia, are independently modulated via the AR, and understanding the contribution of AR and insulin-signaling pathways further may facilitate the development of targeted interventions in high-risk women with PCOS and MetS.


Assuntos
Antagonistas de Androgênios/farmacologia , Glicemia/efeitos dos fármacos , Receptor alfa de Estrogênio/efeitos dos fármacos , Flutamida/farmacologia , Hipoglicemiantes/farmacologia , Insulina/metabolismo , Síndrome Metabólica/metabolismo , Metformina/farmacologia , Animais , Apolipoproteína B-100/efeitos dos fármacos , Apolipoproteína B-100/metabolismo , Apolipoproteína B-48/efeitos dos fármacos , Apolipoproteína B-48/metabolismo , Apolipoproteínas B/efeitos dos fármacos , Apolipoproteínas B/metabolismo , Glicemia/metabolismo , Doenças Cardiovasculares , Modelos Animais de Doenças , Receptor alfa de Estrogênio/genética , Feminino , Fase Folicular , Resistência à Insulina , Mucosa Intestinal/metabolismo , Fígado/efeitos dos fármacos , Fígado/metabolismo , Proteína Quinase 1 Ativada por Mitógeno/efeitos dos fármacos , Proteína Quinase 1 Ativada por Mitógeno/metabolismo , Folículo Ovariano/efeitos dos fármacos , Ovário/efeitos dos fármacos , Síndrome do Ovário Policístico/metabolismo , Proteínas Proto-Oncogênicas c-akt/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-akt/metabolismo , RNA Mensageiro , Ratos , Receptor de Insulina/efeitos dos fármacos , Receptor de Insulina/metabolismo , Risco , Triglicerídeos/metabolismo
2.
Acta Crystallogr D Biol Crystallogr ; 70(Pt 6): 1770-8, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24914987

RESUMO

The phytopathogenic Gram-negative bacterium Dickeya dadantii (Erwinia chrysanthemi) feeds on plant cell walls by secreting pectinases and utilizing the oligogalacturanate products. An outer membrane porin, KdgM, is indispensable for the uptake of these acidic oligosaccharides. Here, the crystal structure of KdgM determined to 1.9 Šresolution is presented. KdgM is folded into a regular 12-stranded antiparallel ß-barrel with a circular cross-section defining a transmembrane pore with a minimal radius of 3.1 Å. Most of the loops that would face the cell exterior in vivo are disordered, but nevertheless mediate contact between densely packed membrane-like layers in the crystal. The channel is lined by two tracks of arginine residues facing each other across the pore, a feature that is conserved within the KdgM family and is likely to facilitate the diffusion of acidic oligosaccharides.


Assuntos
Bactérias Gram-Negativas/química , Oligossacarídeos/química , Porinas/química , Sequência de Aminoácidos , Sequência de Bases , Primers do DNA , Dados de Sequência Molecular , Homologia de Sequência de Aminoácidos
3.
Praxis (Bern 1994) ; 100(22): 1371-3, 2011 Nov 02.
Artigo em Alemão | MEDLINE | ID: mdl-22048914

RESUMO

The acute calcific tendinitis of the longus colli muscle is a rare inflammatory process of the prevertebral muscles. The clinical picture includes acute neck pain, limited range of motion of the cervical spine with stiffness and odynophagia. The laboratory findings demonstrate inflammatory signs. The incidence of the disease peaks between the third and sixth decade. The knowledge of the characteristic radiologic findings and the self-limiting course prevents the patient from needless medical and surgical interventions.


Assuntos
Vértebras Cervicais/patologia , Condrocalcinose/diagnóstico , Cervicalgia/etiologia , Doenças da Coluna Vertebral/diagnóstico , Tendinopatia/diagnóstico , Adulto , Atlas Cervical/patologia , Diagnóstico Diferencial , Feminino , Humanos , Imageamento por Ressonância Magnética , Processo Odontoide/patologia , Tomografia Computadorizada por Raios X
4.
Langmuir ; 23(18): 9365-8, 2007 Aug 28.
Artigo em Inglês | MEDLINE | ID: mdl-17676881

RESUMO

We introduce a method for reversibly orienting long-chain DNA on solid hydrophilic substrates without a fluid meniscus. End-tethered lambda-DNA mushrooms are elongated by a hydrodynamic flow in the presence of trivalent cations, resulting in electrostatic adsorption of the extended DNA to the surface. By complexation of the cations the part of the DNA which is unspecifically bound to the surface desorbs quantitatively, and the mushroom conformation is restored. With the use of multiple deposition-combing steps, combined with a final desorption step, tethering densities higher than attainable with single deposition steps can be obtained.


Assuntos
DNA/química , Análise de Sequência com Séries de Oligonucleotídeos , Plasmídeos/química
5.
Phys Rev Lett ; 96(10): 107801, 2006 Mar 17.
Artigo em Inglês | MEDLINE | ID: mdl-16605791

RESUMO

We use confocal fluorescence microscopy to study the conformation of single DNA molecules end-tethered to a solid substrate. The segment distribution rho(z) measured for chains with contour lengths 15.4 microm

6.
Cell Mol Life Sci ; 61(13): 1633-51, 2004 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15224187

RESUMO

Recent scientific advances have revealed the identity of several enzymes involved in the synthesis, storage and catabolism of intracellular neutral lipid storage droplets. An enzyme that hydrolyzes stored triacylglycerol (TG), triacylglycerol hydrolase (TGH), was purified from porcine, human and murine liver microsomes. In rodents, TGH is highly expressed in liver as well as heart, kidney, small intestine and adipose tissues, while in humans TGH is mainly expressed in the liver, adipose and small intestine. TGH localizes to the endoplasmic reticulum and lipid droplets. The TGH genes are located within a cluster of carboxylesterase genes on human and mouse chromosomes 16 and 8, respectively. TGH hydrolyzes stored TG, and in the liver, the lipolytic products are made available for VLDL-TG synthesis. Inhibition of TGH activity also inhibits TG and apolipoprotein B secretion by primary hepatocytes. A role for TGH in basal TG lipolysis in adipocytes has been proposed. TGH expression and activity is both developmentally and hormonally regulated. A model for the function of TGH is presented and discussed with respect to tissue specific functions.


Assuntos
Lipase/metabolismo , Metabolismo dos Lipídeos , Sequência de Aminoácidos , Animais , Regulação Enzimológica da Expressão Gênica , Humanos , Lipase/química , Lipase/genética , Lipase/isolamento & purificação , Dados de Sequência Molecular , Processamento de Proteína Pós-Traducional , Esteróis/metabolismo , Esteróis/farmacologia
7.
Hear Res ; 192(1-2): 36-46, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15157961

RESUMO

OBJECTIVE: The purpose of the study was to identify acoustcomechanical properties of various biostable and biocompatible materials to create a middle ear prosthesis with the following properties: (i) improved handling including a good view of the head of the stapes or footplate and adjustable length, (ii) improved acoustical characteristics that are adequate for ossiculoplastic. The identified material should serve to build CE and FDA approved prostheses for clinical use in patients. METHODS: Test models made of Teflon, polyetheretherketone, polyethylenterephtalate, polysulfone, gold, Al2O3 ceramics, carbon and titanium were investigated for their potential to fulfill the requirements. Acoustical properties were investigated by laser Doppler velocimetry (LDV) in mechanical middle ear models (MMM). Measured data were fed in to a recently created computer model of the middle ear (multibody systems approach, MBS). Using computer-aided design (CAD) measured and computed data allowed creation and fine precision of titanium prostheses (Tübingen Titanium Protheses, TTP). Their handling was tested in temporal bones. Acoustomechanical properties were investigated using the MBS and mechanical middle ear models. MAIN OUTCOME MEASURES: Input impedance, mass, stiffness, and geometry of test models and prostheses were determined. Furthermore, their influence on the intraprosthetic transfer functions and on coupling to either tympanic membrane or stapes was investigated. RESULTS: Final results were FDA- and CE-approved filigreed titanium prostheses with an open head that fulfilled the four requirements detailed above. The prostheses (TTP) were developed in defined lengths of between 1.75 and 3.5 mm (partial) and 3.0 and 6.5 mm (total) as well as in adjustable lengths (TTP-Vario). CONCLUSIONS: The results suggest acoustomechanical advantages of TTPs because they combine a significantly low mass with high stiffness. In contrast to closed prostheses, the open head and filigreed design allow an excellent view of the prosthesis foot during coupling to the head or footplate of stapes, contributing to an improved intraoperative reliability of prosthesis coupling.


Assuntos
Prótese Ossicular , Acústica , Materiais Biocompatíveis , Fenômenos Biomecânicos , Desenho Assistido por Computador , Humanos , Técnicas In Vitro , Fluxometria por Laser-Doppler , Teste de Materiais , Desenho de Prótese , Titânio
8.
Eur J Surg Oncol ; 29(4): 379-82, 2003 May.
Artigo em Inglês | MEDLINE | ID: mdl-12711293

RESUMO

AIMS: Osteosarcoma is the most frequent malignant bone tumor with a peak incidence in the second and third decade of life. Evaluation of prognosis of patients with osteosarcoma is limited to clinical parameters whereas molecular markers of tumor aggression have not yet been identified. Inhibition of apoptotic cell death could play a role in the development or progression of neoplasia. Survivin is a member of the inhibitor of apoptosis (IAP) protein gene family and is expressed both during normal fetal development and in human cancer. METHODS: The localization and distribution of survivin was investigated immunohistochemically in high-grade osteosarcomas by an indirect immunoperoxidase method. RESULTS: Survivin was detected in the cytoplasm in 23/40 and in the nucleus in 20/40 cases of osteosarcoma. Nuclear localization of survivin expression was significantly correlated with a prolonged survival (P=0.0347) but cytoplasmic staining showed no correlation with patient outcome. CONCLUSIONS: The results of this study indicates that the evaluation of survivin expression might be a useful prognostic marker in osteosarcoma. Patients with osteosarcoma exhibiting nuclear survivin expression could potentially benefit from stratification of neoadjuvant chemotherapy.


Assuntos
Biomarcadores Tumorais/análise , Neoplasias Ósseas/química , Proteínas Associadas aos Microtúbulos/análise , Osteossarcoma/química , Adolescente , Adulto , Idoso , Neoplasias Ósseas/patologia , Criança , Inibidores de Cisteína Proteinase/análise , Feminino , Regulação Neoplásica da Expressão Gênica , Humanos , Imuno-Histoquímica , Proteínas Inibidoras de Apoptose , Masculino , Pessoa de Meia-Idade , Proteínas de Neoplasias , Osteossarcoma/patologia , Valor Preditivo dos Testes , Prognóstico , Análise de Sobrevida , Survivina
9.
Biomed Tech (Berl) ; 47(9-10): 215-8, 2002 Oct.
Artigo em Alemão | MEDLINE | ID: mdl-12369208

RESUMO

The Automated External Defibrillation is the key link of the chain of survival for patients in cardiac arrest. A lot of case series and trials have shown the effectiveness of early defibrillation by first rescuers and trained lay persons. The earlier the defibrillation is performed, the better is the rate of survival to hospital discharge. To increase the survival rate healthcare providers, first rescuer citizens at worksites and trained lay rescuers should be authorized, equipped and encouraged to perform early defibrillation combined with effective cardiopulmonary resuscitation (CPR). The new generation of Automated External Defibrillators (AED) are sophisticated, computerized devices that are reliable and simple to operate, enabling also lay rescuers to administer this lifesaving intervention to victims of cardiac arrest. For the concept of recurrent adequate and qualified training in the use of the AED integrated in effective DPR is recommended.


Assuntos
Pessoal Técnico de Saúde , Morte Súbita Cardíaca/prevenção & controle , Cardioversão Elétrica/instrumentação , Primeiros Socorros/instrumentação , Terapia Assistida por Computador/instrumentação , Fibrilação Ventricular/terapia , Morte Súbita Cardíaca/etiologia , Eletrocardiografia/instrumentação , Desenho de Equipamento , Parada Cardíaca/mortalidade , Parada Cardíaca/terapia , Humanos , Processamento de Sinais Assistido por Computador/instrumentação , Taxa de Sobrevida , Fibrilação Ventricular/mortalidade
10.
Audiol Neurootol ; 6(5): 250-8, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11729327

RESUMO

Local therapy is practiced for middle and inner ear diseases but is usually restricted to cases of ear drum perforation or repeated invasive intratympanic drug application. Perfusion of drugs on the round window or through the scalae of animals using a pump system suggests that the chronic local drug treatment might also be feasible in humans. However, drug delivery systems that are currently on the market involve repeated reimplantation if they are to be used for long-term drug supply. A bone-anchored, totally implantable micro-drug delivery system (MDS) for patient-controlled drug supply has been developed [Lehner et al., 1997]. In this study, we show the first successful long-term in vivo test of the MDS micro-pump in rats. The process of implantation and first functional tests will be described. The biomaterial used to manufacture the delivery system did not cause any inflammation reaction in any of the 9 animals successfully implanted. After activation of the micro-pump, the drug reservoir and port was found to be fluid-tight. Bolus applications of tetrodotoxin (TTX) to the round window induced a transient decrease of evoked brainstem responses. In 2 animals which carried the MDS for more than 8 months the proper functioning of the pumping device was examined in a 2-3 week interval over a 3 month period. The MDS can be autoclaved even after long-term implantation and can then be reused for subsequent implantations. Designed for life-long implantation in humans, the demonstration of an effective long-term drug supply to the inner ear using the MDS provides an encouraging first step towards future long-term drug treatment of the inner ear in humans.


Assuntos
Anestésicos Locais/administração & dosagem , Anestésicos Locais/farmacologia , Cóclea/efeitos dos fármacos , Modelos Animais de Doenças , Bombas de Infusão Implantáveis , Tetrodotoxina/administração & dosagem , Tetrodotoxina/farmacologia , Administração Tópica , Animais , Otopatias/tratamento farmacológico , Potenciais Evocados Auditivos do Tronco Encefálico/efeitos dos fármacos , Masculino , Ratos , Ratos Wistar , Tetrodotoxina/uso terapêutico , Tempo
11.
Ann Otol Rhinol Laryngol ; 110(10): 912-6, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11642422

RESUMO

A subpopulation of hearing-impaired patients has conductive hearing loss that cannot be improved by classic tympanoplasty. Other patients have a mixed hearing loss and cannot be helped by present forms of ear surgery or by hearing aids. Possible help for some patients may come from current implantable hearing devices if these are modified for the patient's specific anatomic situation. The TICA LZ 3001 is a hearing implant for total implantation used to treat moderate to severe sensorineural hearing loss. Most patients who use it have a normal ossicular chain that allows coupling of the implant to the incus. The present temporal bone study demonstrates that the TICA can also be used in patients with an interrupted ossicular chain. If the incus long process shows a defect, the TICA may be coupled to the incus body, and connection between the stapes and the long process of the incus can be achieved with a commercially available titanium-angle prosthesis or liquid ionomeric cement. In cases of an absent incus, the coupling axis of the transducer may be coupled to the stapes head via a modified coupling element. With an absent stapes, the coupling axis may be coupled directly to the perilymph by a coupling element similar to a gold stapes prosthesis.


Assuntos
Orelha Média , Auxiliares de Audição , Perda Auditiva Neurossensorial/terapia , Humanos , Desenho de Prótese , Osso Temporal , Transdutores
12.
Otol Neurotol ; 22(5): 582-9, 2001 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11568662

RESUMO

OBJECTIVE: The overall purpose of the study was the evaluation of the efficacy of Tübingen titanium prostheses (TTPs) for ossiculoplasty. STUDY DESIGN: A two-part clinical study of 216 patients undergoing ossiculoplasty was performed. The first part was a prospective study using TTPs (n = 114). The second part involved study of historical control patients (n = 102) with gold and ceramic prostheses. INTERVENTIONS: All patients underwent ossiculoplasty. MAIN OUTCOME MEASURES: Measures included median air conduction thresholds and air-bone gaps. RESULTS: All patients were per-protocol patients. When the air-bone gap "gold standard" (i.e., < or =10 dB) was investigated in the main speech spectrum, partial TTPs reached this level at 2 kHz in 44% (n = 22) and at 3 kHz in 38% (n = 19). Gold and ceramics revealed significantly lower values. Similar results were obtained for total prostheses. Differences for TTPs and ceramics were statistically significant (Mann-Whitney U test, alpha = 5%). CONCLUSION: The use of TTPs for ossiculoplasty is an efficient treatment method.


Assuntos
Prótese Ossicular , Titânio , Estimulação Acústica/instrumentação , Acústica , Adolescente , Desenho de Equipamento , Feminino , Humanos , Masculino , Estudos Prospectivos , Timpanoplastia
13.
Biochim Biophys Acta ; 1532(3): 162-72, 2001 Jun 29.
Artigo em Inglês | MEDLINE | ID: mdl-11470237

RESUMO

A novel murine cDNA for triacylglycerol hydrolase (TGH), an enzyme that is involved in mobilization of triacylglycerol from storage pools in hepatocytes, has been cloned and expressed. The cDNA consists of 1962 bp with an open reading frame of 1695 bp that encodes a protein of 565 amino acids. Murine TGH is a member of the CES1A class of carboxylesterases and shows a significant degree of identity to other carboxylesterases from rat, monkey and human. Expression of the cDNA in McArdle RH7777 hepatoma cells showed a 3-fold increase in the hydrolysis of p-nitrophenyl laurate compared to vector-transfected cells. The highest expression of TGH was observed in the livers of mice, with lower expression in kidney, heart, adipose and intestinal (duodenum/jejunum) tissues. The murine gene that encodes TGH was cloned and exon-intron boundaries were determined. The gene spans approx. 35 kb and contains 14 exons. The results will permit future studies on the function of this gene via gene-targeting experiments and analysis of transcriptional regulation of the TGH gene.


Assuntos
Lipase/genética , Sequência de Aminoácidos , Animais , Sequência de Bases , Linhagem Celular , Clonagem Molecular , DNA Complementar/química , DNA Complementar/isolamento & purificação , Éxons , Regulação da Expressão Gênica , Íntrons , Lipase/química , Fígado/enzimologia , Camundongos , Dados de Sequência Molecular , Fases de Leitura Aberta , Ratos , Mapeamento por Restrição , Alinhamento de Sequência , Transfecção
14.
Obstet Gynecol ; 97(6): 965-70, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11384704

RESUMO

OBJECTIVE: To find if a difference in telomerase or survivin expression exists between non-neoplastic tissues and hydatidiform moles, and explore expression of those proteins in normal placental development, post-term gestation, and preeclampsia. METHODS: Formalin-fixed placental tissues were selected from collections of the Department of Pathology at the University of Colorado. Five specimens of each trimester, five each of preeclamptic and post-term placentas, and 23 molar pregnancies were selected. The telomerase catalytic protein hTERT was localized in placental tissues using the catalyzed signal amplification system, and survivin was localized by conventional immunoperoxidase method. Staining was graded on a scale of zero to 4. RESULTS: hTERT staining was detected in sections of 42 of 48 specimens (23 of 23 hydatidiform moles, 19 of 25 non-neoplastic placental tissues). The intensity of staining for hTERT was higher in hydatidiform moles (mean 3.3, median 3) compared with levels in non-neoplastic placental tissues (mean 0.92, median 1) (P <.001). Survivin was detected in 39 of 48 specimens (22 of 23 hydatidiform moles, 17 of 25 non-neoplastic placental tissues). Compared with non-neoplastic tissues (mean 0.88, median 1), survivin levels were elevated in hydatidiform moles (mean 1.35, median 1) (P =.031). CONCLUSION: Survivin and telomerase were increased in hydatidiform moles, suggesting that regulation of apoptosis and stabilization of telomere length might be involved in neoplastic transformation of the placenta. The patterns of expression observed for survivin and telomerase in non-neoplastic placental tissues suggest that the control of apoptosis and stabilization of telomeric DNA might also be involved in normal gestational development.


Assuntos
Mola Hidatiforme/patologia , Proteínas Associadas aos Microtúbulos , Placenta/metabolismo , Placenta/patologia , Pré-Eclâmpsia/patologia , Proteínas/análise , RNA , Telomerase/análise , Biomarcadores/análise , Técnicas de Cultura , Proteínas de Ligação a DNA , Feminino , Humanos , Imuno-Histoquímica , Proteínas Inibidoras de Apoptose , Proteínas de Neoplasias , Placentação , Gravidez , Gravidez Prolongada , Probabilidade , Valores de Referência , Sensibilidade e Especificidade , Estatísticas não Paramétricas , Survivina
15.
J Biol Chem ; 276(27): 25621-30, 2001 Jul 06.
Artigo em Inglês | MEDLINE | ID: mdl-11337511

RESUMO

Microsomal triacylglycerol hydrolase (TGH) hydrolyzes stored triacylglycerol in cultured hepatoma cells (Lehner, R., and Vance, D. E. (1999) Biochem. J. 343, 1-10). We studied expression of TGH in murine liver and found both protein and mRNA increased dramatically at 27 days after birth. Nuclear run-on assays demonstrated that this was due to increased transcription. We cloned 542 base pairs upstream of the transcriptional start site of the murine TGH gene. Electrophoretic mobility shift assays demonstrated enhanced binding of hepatic nuclear proteins from 27-day-old mice to the murine TGH promoter, yielding three differentially migrating complexes. DNase I footprint analysis localized these complexes to two distinct regions: site A contains a putative Sp binding site, and site B contains a degenerate E box. We transfected primary murine hepatocytes with a series of 5'-deletion constructs upstream of the reporter luciferase cDNA. Positive control elements were identified in a segment containing site A. Competitive electrophoretic mobility shift assays and supershift assays demonstrated that site A binds Sp1 and Sp3. Transcriptional activation assays in Schneider SL-2 insect cells demonstrated that Sp1 is a potent activator of the TGH promoter. These experiments directly link increased TGH expression at the time of weaning to transcriptional regulation by Sp1.


Assuntos
Lipase/genética , Fígado/enzimologia , Fator de Transcrição Sp1/fisiologia , Transcrição Gênica , Animais , Sequência de Bases , Sítios de Ligação , Linhagem Celular , DNA Complementar/química , Proteínas de Ligação a DNA/metabolismo , Eletroforese em Gel de Poliacrilamida , Genes Reporter , Lipase/biossíntese , Lipoproteínas VLDL/metabolismo , Luciferases/genética , Camundongos , Dados de Sequência Molecular , Regiões Promotoras Genéticas , RNA Mensageiro/biossíntese , Fator de Transcrição Sp3 , Spodoptera , Fatores de Transcrição/metabolismo
16.
Arch Gynecol Obstet ; 265(1): 36-9, 2001 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11327092

RESUMO

BACKGROUND: The aim of this retrospective study was to evaluate whether a delay between a preliminary exploratory laparotomy and a definitive staging laparotomy and interval chemotherapy between the two operations affected the prognosis of ovarian cancer. METHODS: Of 504 patients with malignant tumors of the ovary who were treated at the Department of Obstetrics and Gynecology between 1980 and 1993, there were 24 who had a delayed definitive staging laparotomy. RESULTS: Sixteen patients did not have chemotherapy between their two operations. After definitive laparotomy, 13 patients (54.2%) were free of disease and 11 patients had residual disease (45.8%). CONCLUSIONS: The value of chemotherapy between preliminary and definitive laparotomy in halting tumor growth was not demonstrated by the results of our analysis.


Assuntos
Neoplasias Ovarianas/cirurgia , Adulto , Antineoplásicos/uso terapêutico , Terapia Combinada , Feminino , Humanos , Menopausa , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Neoplasias Ovarianas/diagnóstico por imagem , Neoplasias Ovarianas/patologia , Prognóstico , Fatores de Tempo , Ultrassonografia
17.
Hum Pathol ; 32(1): 119-25, 2001 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11172305

RESUMO

The regulation of apoptotic cell death may have a profound effect on the pathogenesis and progression of colon cancer. Survivin, a member of the inhibitor of apoptosis gene family, has been detected in fetal tissue and in a variety of human malignancies. In the current study, we investigated survivin expression by an immunohistochemical approach in benign, hyperplastic, premalignant, and malignant lesions of the colon. Survivin was detected in all cases of normal colonic mucosa (20/20), hyperplastic polyps (20/20), adenomatous polyps (20/20), and in both well differentiated and moderately differentiated colonic adenocarcinomas (20/20). In the normal colonic mucosa, survivin expression was mostly restricted to the base of the colonic crypts. All epithelial cells showed uniformly intense staining for survivin in hyperplastic polyps. By contrast, adenomas and adenocarcinomas showed a heterogeneous staining pattern with cell-to-cell, gland-to-gland, and regional variability in the intensity of survivin staining. In contrast to the basal preponderance of staining in normal colonic mucosa, numerous survivin positive cells were present at the luminal surface of hyperplastic polyps, adenomatous polyps, and adenocarcinomas. In conclusion, the expression of survivin is not a specific marker of adenocarcinoma of the colon but does show characteristic and reproducible patterns of expression in non-neoplastic proliferative lesions and in normal colonic mucosa.


Assuntos
Colo/patologia , Neoplasias do Colo/patologia , Mucosa Intestinal/patologia , Proteínas Associadas aos Microtúbulos , Biossíntese de Proteínas , Colo/química , Neoplasias do Colo/metabolismo , Células HeLa , Humanos , Hiperplasia , Imuno-Histoquímica , Proteínas Inibidoras de Apoptose , Mucosa Intestinal/química , Queratinas/análise , Antígeno Ki-67/análise , Proteínas de Neoplasias , Survivina
20.
Eur J Obstet Gynecol Reprod Biol ; 99(2): 272-3, 2001 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-11788187

RESUMO

We describe a case with placental, and general metastases, resulting in transient intrauterine and general hypoxia, and with additionally clinical features similar to HELLP syndrome. A patient in the third trimester with dyspnea at rest developed right heart failure during c-section. During emergency thoracotomy the patient went into generalized shock and died after intense CPR. Placental insufficiency was based on a multilocal metastatic event, decreasing the utero-placental perfusion.


Assuntos
Neoplasias da Mama/complicações , Idade Gestacional , Metástase Neoplásica/patologia , Insuficiência Placentária/etiologia , Complicações Neoplásicas na Gravidez , Adulto , Neoplasias da Mama/patologia , Carcinoma Ductal de Mama/complicações , Carcinoma Ductal de Mama/patologia , Evolução Fatal , Feminino , Humanos , Recém-Nascido , Insuficiência Placentária/patologia , Gravidez , Terceiro Trimestre da Gravidez
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...